InvestorsHub Logo
Followers 0
Posts 5922
Boards Moderated 4
Alias Born 09/04/2008

Re: StocksOnWatch post# 7467

Monday, 04/27/2009 9:42:53 AM

Monday, April 27, 2009 9:42:53 AM

Post# of 7611
MCET +50% has a $1.4M market cap and is trading at $0.01. According to the company’s website, their MCT-465 drug candidate is a Toll-like Receptor (TLR) agonist, and is indicated as prospective therapy for treatment of virus infections including influenza A H1N1 and the “avian flu” virus.



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.